Maxheal Pharmaceuticals (India) Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Maxheal Pharmaceuticals (India) Limited

Maxheal Pharmaceuticals (India) Limited, a active public limited company, was established on 29 June 2009 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U73100MH2009PLC193624. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Maxheal Pharmaceuticals Limited. It upholds a compliant status. Employing 67 professional, Its leadership includes Pranita Mehul Sakhala (Director), Hemlata Madanlal Sakhala (Director), Madanlal Mohanlal Sakhala (Director). Past directors included Madanlal Mohanlal Sakhala, Mehul Madan Sakhala. It holds ₹33.68 Cr open charges and ₹91.87 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 301, 3Rd Floor, Maxheal House, Plot No. Cst No. 1043, Bangur Nagar, Goregaon (We, St), Mumbai, Maharashtra, 400090.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100MH2009PLC193624

  • Registration Number

    193624

  • Incorporation Date

    29 June 2009

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 16 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 33.68 Cr
  • Satisfied Charges ₹ 91.87 Cr
  • Revenue Growth **** 10.48%
  • Profit Growth **** -37.17%
  • Ebitda **** -27.29%
  • Net Worth 1.77%
  • Total Assets **** 1.00%
Company report

Maxheal Pharmaceuticals (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maxheal Pharmaceuticals (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maxheal Pharmaceuticals (India) Limited?
Current Directors
Name Designation Appointment Date Status
Pranita Mehul Sakhala Director 01 Jul 2017 Current
Hemlata Madanlal Sakhala Director 29 Jun 2009 Current
Madanlal Mohanlal Sakhala Director 01 Jul 2012 Current
Mehul Madan Sakhala Managing Director 29 Jun 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 30 Jun 2017 Past
Pramod Abcsdd Director 01 Jul 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxheal Pharmaceuticals (India).

Maxheal Pharmaceuticals (India) Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.48% increase. The company also saw a substantial fall in profitability, with a 37.17% decrease in profit. The company's net worth moved up by a moderate rise of 1.77%.

Maxheal Pharmaceuticals (India) revenue growth over time
Maxheal Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.48%
*******
*******
*******
*******
Revenue from Operations
*******
 15.06%
*******
*******
*******
*******
Total Assets
*******
 1.00%
*******
*******
*******
*******
Profit or Loss
*******
 -37.17%
*******
*******
*******
*******
Net Worth
*******
 1.77%
*******
*******
*******
*******
EBITDA
*******
 -27.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxheal Pharmaceuticals (India)?

In 2024, Maxheal Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹336,800,000.00

Satisfied Charges

₹918,700,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 33.68 Cr
Latest Charge Details
Date Lender Amount Status
13 Jul 2010 State Bank Of India ₹33.68 Cr Open
18 Jan 2021 Others ₹2.56 Cr Satisfied
26 May 2020 Others ₹1.20 Cr Satisfied
02 May 2018 State Bank Of India ₹10.05 Cr Satisfied
20 May 2017 Others ₹4.47 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Maxheal Pharmaceuticals (India)?

Maxheal Pharmaceuticals (India) has a workforce of 67 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxheal Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxheal Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxheal Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Maxheal Pharmaceuticals (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Maxheal Pharmaceuticals (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    A charge registered on 02 May 2018 via Charge ID 100175524 with State Bank Of India was fully satisfied on 20 May 2023. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India of Rs. 33.68 Cr registered on 13 Jul 2010 with Charge ID 10232163 was modified on 20 Feb 2023. was recorded as a recent event.

  • Charges

    The activity A charge registered on 02 Sep 2011 via Charge ID 10306801 with Others was fully satisfied on 24 Mar 2022. was completed.

  • Charges

    The activity A charge registered on 18 Jan 2021 via Charge ID 100409547 with Others was fully satisfied on 16 Oct 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxheal Pharmaceuticals (India) Limited?

The CIN of Maxheal Pharmaceuticals (India) Limited is U73100MH2009PLC193624.

Where is Maxheal Pharmaceuticals (India) Limited headquartered?

Maxheal Pharmaceuticals (India) Limited is headquartered at 301, 3Rd Floor, Maxheal House, Plot No. Cst No. 1043, Bangur Nagar, Goregaon (We, St), Mumbai, Maharashtra, 400090.

When was Maxheal Pharmaceuticals (India) Limited incorporated?

Maxheal Pharmaceuticals (India) Limited was incorporated on 29 June 2009.

Who are the current directors of Maxheal Pharmaceuticals (India) Limited?

The current directors of Maxheal Pharmaceuticals (India) Limited are

What is the primary industry of Maxheal Pharmaceuticals (India) Limited?

The primary industry of Maxheal Pharmaceuticals (India) Limited is Manufacturing.

Is Maxheal Pharmaceuticals (India) Limited a listed company?

Maxheal Pharmaceuticals (India) Limited is unlisted.

What is the capital structure of Maxheal Pharmaceuticals (India) Limited?

The authorized capital of Maxheal Pharmaceuticals (India) Limited is ₹4.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Maxheal Pharmaceuticals (India) Limited?

The compliance status of Maxheal Pharmaceuticals (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available